Scalable Generation of Clinical-Grade Universal Human cDC1s Enables Potent Antitumor Immunotherapy
C. Liu, S. Bi, W. Chen, Y. Tian, H. Li, G. Li, H. Li, Y. Wang, L. Wu, H. Zhou
This paper develops a scalable method to generate clinical-grade cDC1s from umbilical cord blood, showing improved antitumor efficacy in mouse models and recapitulating DC differentiation.
bioRxiv · Jan 15, 2026 · PreprintImmunology